CMS CMS Releases Second Interim Final Rule on Surprise Billing Thomas Sullivan Oct 19, 2021 0 On September 30, 2021, the Centers for Medicare and Medicaid Services (CMS) issued an interim final rule (IFR) to address large…
False Claims Act Sutter Health Reaches Largest FCA Settlement Against Hospital System for… Thomas Sullivan Oct 18, 2021 0 Major California hospital system Sutter Health is settling whistleblower allegations of risk adjustment fraud for $90 million, the…
CME Illinois Health Care Professionals Must Learn About Alzheimer’s Thomas Sullivan Oct 15, 2021 0 Recently, Illinois Governor JB Pritzker signed legislation that mandates licensed health care professionals who treat patients 26…
FDA FDA Issues Draft Guidance on RWD Sourced from EHRs and Medical Claims Data Thomas Sullivan Oct 14, 2021 0 In late September 2021, the United States Food and Drug Administration (FDA) issued draft guidance, Real-World Data: Assessing…
FDA FDA REMS Pain Management and Opioid Therapy: Persistent Knowledge Gaps… Thomas Sullivan Oct 13, 2021 0 The opioid epidemic that has gripped the US for over 20 years has worsened during the ongoing COVID-19 pandemic with the highest…
Pharmaceutical Representative Disclosure Oregon Publishes Proposed Rules on Pharmaceutical Representative Licensure… Thomas Sullivan Oct 12, 2021 0 On October 5, Oregon’s Department of Consumer and Business Services (“DCBS”) held a public meeting to discuss the proposed rules…
FDA FDA Requests Input on How to Handle Post-Approval Regulation of PANDAs Thomas Sullivan Oct 11, 2021 0 The US Food and Drug Administration (FDA) recently asked for input from stakeholders on how it should handle certain drugs…
CMS CMS Issues IPPS Final Rule for FY 2022 Thomas Sullivan Oct 8, 2021 0 On August 2, 2021, the Centers for Medicare and Medicaid Services (CMS) issued its hospital inpatient prospective payment system…
CME California Law Makes Changes to CME Thomas Sullivan Oct 7, 2021 0 Recently, the State of California enacted Assembly Bill 359, which would expand the definition of continuing medical education…
Congress Biopharmaceutical Companies Send Open Letter to Congress Thomas Sullivan Oct 6, 2021 0 On September 15, 2021, member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) made public an open…